enGene Therapeutics Inc. (ENGN) › EPS (Basic)enGene Therapeutics Inc. (ENGN) — EPS (Basic)Annual figures by period end, from SEC filings.2022-10-31: $44.302023-10-31: $151.222024-10-31: $1.462025-10-31: $2.29$2.292022-10-31EPS (Basic) (USD/shares)2025-10-31Period endedEPS (Basic)Change YoYSource filing2025-10-31$2.29+56.8%2025-12-22From 2024-11-012024-10-31$1.46-99.0%2025-12-22From 2023-11-012023-10-31$151.22+241.4%2024-12-19From 2022-11-012022-10-31$44.30—2024-01-29From 2021-11-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares